The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
This is a massive buy at these levels.
I make this a £13m mcap?
Should be more like 15-16p fair value
Fantastic cash balance, revenue + EBITDA progressing year on year quite agressively.
I'm sure the herd will arrive soon 🙈
46p still looks cheap.
I agree.. 55p by end of the week.
This morning's activity starting to suggest it could be.. any of the two active shorts close or reduce and this thing could fly back to 60/70p
Monday morning open could be interesting
Surprised we haven't seen a recovery yet - lower CPI should have seen a bounce.. but I'm fairly certain this sees 60p again shortly
Where you see it at 46p today... Then you look again in 12 months and work out what you could have won if you'd have bought/held at these levels.
...As a result, looking at the remainder of the year, Watkin Jones told investors it would no longer expect to materially improve on the £2mln of underlying profit reported previously for the first half. That forecast is based on the firm having no completions of forward sales by the end of 2023.
Meanwhile, it downgraded the profit forecast for 2024 by setting a range of £15-20mln.
So 2024 expected profit of £15-20m... Mcap £120m
Too low.
Recovery coming.
No justification for a near 50% drop here
Will be back towards 70 by the end of the week.
Not at all - genuinely not a deramper whatsoever. I read today's RNS with some real interest and I am considering investment... But I just don't see the value at a £2.5b mcap.
Feel free to jump down my throat, but my question was genuine.
Very clear that the MMs are trying to create some liquidity here
9 trades today (7 buys, 2 sells) suggests yesterday's drop had a partial impact
But until the volume arrives, the MMs may continue fishing for stops by dropping the bid/offer.
Currently 1.6/1.5
If you can sit on your hands this will eventually come good.
Will only take one RNS relating to the completion of the new plant (due by end of July) and/or some some new order/revenue streams (I suspect the MXC RNS from last week will have a knock on effect soon!)
Hold. Or, if you can - buy more at 1.6!
Only my opinion - but I am certain this will come good.
Looks like the initial 2.5/2.4 drop was off the back of a £300 'at best' sell at 1.78 - someone must be absolutely crazy to sell at that
Anyway - looks like the market has then been spooked and now we sit at 2.1/2.0
Frightening levels - a £2m mcap down here at these levels 🤯
Still a hold for me.
At some point, someone has to come sniffing and will just take the company out at a £2m mcap.
You have m
So we had two positive RNS in the last week.. looks like we'll have another on Monday...
In August 2022 MXC Pharma placed an order for $1m of ArtemiC (50,000 units) which they in turn sold on to AMC Pharma.
On Friday, MXC announced a 2nd order for the same amount and value, see RNS below.
https://www.lse.co.uk/rns/MXC/amc-places-another-us1m-order-of-artemic8482-6wqp995tp384oes.html
I suspect we will have a follow on RNS from Graft on Monday morning to confirm.
This simply cannot stay at this level for much longer.
For anyone that takes any note of RSI... You might be interested to know it's 2.8
Yes... 2.8
Oversold. Buy.
Zak Mir predicted a gap fill back to around 8p when this was 4.5p, clearly he got that wrong, but I simply cannot find enough downside risk here at 2.8p